Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.
about
Compensatory angiogenesis and tumor refractorinessThe promises of quantitative systems pharmacology modelling for drug developmentPharmacokinetics of Anti-VEGF Agent Aflibercept in Cancer Predicted by Data-Driven, Molecular-Detailed Model.Predictive model of thrombospondin-1 and vascular endothelial growth factor in breast tumor tissueMulti-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.Editorial: The emerging discipline of quantitative systems pharmacology.
P2860
Systems pharmacology approaches for optimization of antiangiogenic therapies: challenges and opportunities.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Systems pharmacology approache ...... challenges and opportunities.
@ast
Systems pharmacology approache ...... challenges and opportunities.
@en
type
label
Systems pharmacology approache ...... challenges and opportunities.
@ast
Systems pharmacology approache ...... challenges and opportunities.
@en
prefLabel
Systems pharmacology approache ...... challenges and opportunities.
@ast
Systems pharmacology approache ...... challenges and opportunities.
@en
P2860
P356
P1476
Systems pharmacology approache ...... challenges and opportunities.
@en
P2093
Satish Sharan
Sukyung Woo
P2860
P356
10.3389/FPHAR.2015.00033
P577
2015-02-20T00:00:00Z